Given these considerations and the absence of published data about the performance of Xpert Ultra in TB pericarditis (TBP), we performed a prospective study evaluating Xpert Ultra against a host biomarker, unstimulated interferon γ (IFNγ; IRISA-TB [Antrum Biotech]). Here, IFNG is linked to tuberculosis.